Medtronic MDT came up with a mixed performance for the third quarter of fiscal 2025, sparking investor concerns and a ...

Medtronic PLC (MDT) reports robust revenue and EPS growth, driven by innovations in Cardiac Ablation and Leadless Pacing, ...

Medtronic Plc (NYSE:MDT) reported third-quarter 2025 sales of $8.29 billion, missing the consensus of $8.32 billion. The ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...

Medtronic (MDT) stock slips as the company reaffirms full-year outlook after delivering mixed financial for Q3 fiscal 2025.

Medtronic (NYSE: MDT) recently announced its Q3 fiscal 2025 results (fiscal ends in April), reporting revenue of $8.29 billion, slightly below the $8.33 billion consensus estimate. Adjusted ...

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

Reports Q3 revenue $8.29B, consensus $8.33B. “We delivered strong earnings this quarter, with significant improvements in both our gross margin ...

Shares of Medtronic ( MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday. The decline came after the medical device ...

Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

Our Q3 revenue of $8.3 billion grew 4.1% organic ... and I look forward to your continued contributions to Medtronic. Now, Terry will be joining us in a couple of weeks. And as I've heard from ...